InterventionsHumans

Comparative 5-Year Mortality Risk in Stage IV-V Chronic Kidney Disease Patients with Prior Myocardial Infarction: Standard Therapy With versus Without SGLT2 Inhibitors

AHA Scientific Sessions 2025 Abstract

The paper

Shahin H, Seylani A, Andrade M et al.

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4370923

doi.org/10.1161/circ.152.suppl_3.4370923

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Clinical Pharmacology and Therapeutics · 4 Oct 2026
Blood protein links to heart attacks vary with kidney function
Kidney Research and Clinical Practice · 6 Oct 2026